Cindy Boer

Microbiome Composition, Joint Pain and Inflammation | 249 5.2 (2016). 23. Huang, Z. & Kraus, V. B. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat. Rev. Rheumatol. 12, 123–129 (2015). 24. Metcalfe, D. et al. Does endotoxaemia contribute to osteoarthritis in obese patients? Clin. Sci. (Lond.). 123, 627–634 (2012). 25. Schott, E. M. et al. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight 3 (2018). 26. Deschasaux, M. et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24, 1526–1531 (2018). 27. Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016). 28. Capurso, G. & Lahner, E. The interaction between smoking, alcohol and the gut microbiome. Best. Pract. Res. Clin. Gastroenterol. 31, 579–588 (2017). 29. Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740–748 (2016). 30. Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017). 31. Gloor, G. B., Wu, J. R., Pawlowsky-Glahn, V. & Egozcue, J. J. It’s all relative: analyzing microbiome data as compositions. Ann. Epidemiol. 26, 1–8 (2016). 32. Schiphof, D. et al. Sensitivity and associations with pain and body weight of an MRI definition of knee osteoarthritis compared with radiographic Kellgren and Lawrence criteria: a popula- tion-based study in middle-aged females. Osteoarthr. Cartil. 22, 440–446 (2014). 33. Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V. & Egozcue, J. J. Microbiome datasets are com- positional: and this is not optional. Front. Microbiol. 8, 2224 (2017). 34. Sinha, R., Abnet, C. C., White, O., Knight, R. & Huttenhower, C. The microbiome quality control project: baseline study design and future directions. Genome Biol. 16, 276 (2015). 35. McGuire, T., Gerjarusak, P., Hinthorn, D. R. & Liu, C. Osteomyelitis caused by beta-hemolytic strep- tococcus group B. JAMA 238, 2054–2055 (1977). 36. Murillo, O. et al. Streptococcal vertebral osteomyelitis: multiple faces of the same disease. Clin. Microbiol. Infect. 20, O33–O38 (2014). 37. Cunningham, M. W. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int. Rev. Immunol. 33, 314–329 (2014). 38. Tandon, R. et al. Revisiting the pathogenesis of rheumatic fever and carditis. Nat. Rev. Cardiol. 10, 171–177 (2013). 39. Mackie, S. L. & Keat, A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheu- matology 43, 949–954 (2004). 40. Barash, J. Rheumatic fever and post-group A streptococcal arthritis in children. Curr. Infect. Dis. Rep. 15, 263–268 (2013). 41. Dewhirst, F. E. et al. The human oral microbiome. J. Bacteriol. 192, 5002–5017 (2010). 42. Pei, Z. et al. Bacterial biota in the human distal esophagus. Proc. Natl Acad. Sci. USA 101, 4250– 4255 (2004). 43. Bik, E. M. et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl Acad. Sci. USA 103, 732–737 (2006). 44. Ikram, M. A. et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur. J. Epidemiol. 32, 807–850 (2017). 45. Fadrosh, D. W. et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequenc- ing on the Illumina MiSeq platform. Microbiome 2, 6 (2014). 46. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).